Sherene Mason, MD, MBAPractice Name: Connecticut Children's Specialty Group
BS, University of Connecticut, 1997
MBA, University of Connecticut School of Medicine, 2006
MD, University of Connecticut School of Medicine, 2006
Pediatrics, Yale-New Haven Children’s Hospital, 2007-2010 (Chief Resident 2009-2010)
Pediatric Nephrology, Yale University School of Medicine, 2010-2013
Assistant Professor of Pediatrics, University of Connecticut School of Medicine
Dr. Mason completed her pediatric residency, a year as Chief Resident, and fellowship in Pediatric Nephrology at Yale University School of Medicine. During her fellowship Dr. Mason completed research examining pathways important in renal tubular repair following renal injury. She was awarded the American Society of Pediatric Nephrology Fellow’s Research Award in Basic Science for her work. She has a strong interest in congenital abnormalities of the kidney and urinary tract, mechanisms underlying acute and chronic kidney disease and renal transplantation. She is a member of several professional organizations, including the American Society of Pediatric Nephrology, the American Academy of Pediatrics and the American Society of Nephrology.
Mason S, Hader C, Marlier A, Moeckel G, Cantley LG. Met activation is required for early cytoprotection after ischemic kidney injury. J Am Soc Nephrol. 2014 Feb; 25(2):329-37.
Koraishy FM, Silva C, Mason S, Wu D, Cantley LG. Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and promotes canonical Wnt signaling. J Biol Chem. 2014 May; 289: 14341-14350.